Meghmani Organics is living up to the promise of being a “classic turnaround story” with “huge upside” by reporting block-buster Q2FY15 results. Daljeet Kohli, the discoverer of the stock, has reiterated his buy call and target price of Rs. 34
Can We Ignore A “Deep Moat” Stock Backed By Rakesh Jhunjhunwala, Radhakishan Damani, Prof. Shivanand Mankekar, Kenneth Andrade & Prashant Jain?
MCX boasts of a galaxy of savvy investors on its rolls who’ve been attracted to it owing to its “deep moat”. We need to keep an eye and also ponder over whether we should join them and share in the riches
Looking For Inspiration? Check Out Warren Buffett’s 5 Multi-Bagger Stock Picks
Warren Buffett is the most inspiring investor you will ever meet. Just gazing at his portfolio of super-duper multi-bagger stocks will fill you with enthusiasm to buy and hold top-quality stocks
Why We Should Buy Stocks Aggressively Now: Prashant Jain
Prashant Jain, CIO of HDFC Mutual Fund, has delivered a talk in which he has explained why we should buy stocks aggressively now
Ravi Dharamshi Of ValueQuest Reveals Favourite Stocks In Portfolio
Ravi Dharamshi, Founder & MD of ValueQuest has identified his favourite stocks and discussed them at length
Panasonic Seeks To Scare Punters Away From De-listing Offer
After Ricoh, Fulford & DIC, it is now the turn of Panasonic to try to scare off punters so that it can finish the de-listing of its shares in peace. Will the punters oblige and leave it alone?
Meet The Stalwarts Rakesh Jhunjhunwala Considers His “Gurus”/ “Mentors”
Rakesh Jhunjhunwala, the Badshah of Dalal Street, on the occasion of his 50th birthday, paid rich tribute to Radhakishan Damani, Nemish Shah and few other stalwarts of the stock market. Though the event happened a couple of years ago, it is worth revisiting it
Why Did Nandita Agarwal Parker Of Karma Capital Buy Rico Auto?
Nandita Agarwal Parker Of Karma Capital is renowned for her “contrarian” & “value” picks. Her latest stock pick is Rico Auto. We need to keep an eye on the developments
Should We Buy Vaibhav Global Ahead Of Its Q2FY15 results?
Vaibhav Global’s business model of retailing through home TV shopping business model is highly scalable with limited investment. It’s Q1FY15 results got impacted owing to a one-time affair. Q2FY15 is a seasonally weak quarter. However, the management’s assertion that things will be normal in Q3FY15 suggests that we need to look into the matter closely
Should We Buy Or Sell Ajanta Pharma Now?
Ajanta Pharma has been a great wealth-creator stock. It reported robust Q2FY15 results. However, have the valuations run up ahead of fundamentals and should we sell the stock?
Recent Comments